Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study
Table 1
Demographic characteristics at baseline.
Group A
Group B
P-value*
Gender
0.74
Female
10 (27.78)
11 (34.38)
Male
26 (72.22)
21 (65.63)
Age (yrs)
0.68
Age
0.78
<65
28 (77.78)
23 (71.88)
≥65
8 (22.22)
9 (28.13)
BT
0.43
Hematoma volume
0.94
Craniotomy
1.00
No
25 (69.44)
22 (68.75)
Yes
11 (30.56)
10 (31.25)
Midline deviation
1.00
No
30 (85.71)
28 (87.50)
Yes
5 (14.29)
4 (12.50)
GPT
0.57
GOT
0.40
BUN
0.21
Creatinine
0.34
PT
0.57
PTT
0.62
Hb
0.10
Plt
0.68
Hypertension
0.23
No
15 (41.67)
8 (25.00)
Yes
21 (58.33)
24 (75.00)
Hyperlipidemia
0.47
No
36 (100.00)
31 (96.88)
Yes
0 (0.00)
1 (3.13)
Hyperuricemia
1.00
No
35 (97.22)
32 (100.00)
Yes
1 (2.78)
0 (0.00)
DM
0.14
No
34 (94.44)
26 (81.25)
Yes
2 (5.56)
6 (18.75)
ICU
0.46
No
3 (8.33)
5 (15.63)
Yes
33 (91.67)
27 (84.38)
Angina
0.47
No
36 (100.00)
31 (96.88)
Yes
0 (0.00)
1 (3.13)
Anemia
1.00
No
35 (97.22)
31 (96.88)
Yes
1 (2.78)
1 (3.13)
DU bleeding
1.00
No
35 (97.22)
32 (100.00)
Yes
1 (2.78)
0 (0.00)
COPD
0.47
No
36 (100.00)
31 (96.88)
Yes
0 (0.00)
1 (3.13)
Arrhythmia
—
No
36 (100.00)
32 (100.00)
Yes
0 (0.00)
0 (0.00)
RCC
1.00
No
35 (97.22)
32 (100.00)
Yes
1 (2.78)
0 (0.00)
TB
1.00
No
35 (97.22)
32 (100.00)
Yes
1 (2.78)
0 (0.00)
Hypercholesterolemia
0.47
No
36 (100.00)
31 (96.88)
Yes
0 (0.00)
1 (3.13)
() represent %; Group A: complementary therapy with Astragalus membranaceus; Group B: complementary therapy with placebo; BT: body temperature; craniotomy: craniotomy treatment with craniotomy; midline deviation: midline of brain deviated to right hemisphere or left hemisphere; GPT: glutamic pyruvic transaminase; GOT: glutamic oxaloacetic transaminase; BUN: blood urea nitrogen; PT: prothrombin time; PTT: partial thromboplastin; Hb: hemoglobin; Plt: platelets; DM: diabetes mellitus; ICU: intensive care unit; Angina: angina pectoris; DU bleeding: duodenal ulcer bleeding; COPD: chronic obstructive pulmonary disease: RCC: coronary care unit; TB: pulmonary tuberculosis. *-test for independent groups was used for used the continuous data; chi-square test or fisher’s exact test for categorical data.